Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies.
Natalia A IlyushinaTakashi E KomatsuWilliam L InceEric F DonaldsonNicolette LeeJulian J O'RearRaymond P DonnellyPublished in: Virology journal (2019)
Although the mechanism by which HA mutations emerge during NAI treatment is uncertain, some NAI treatment-emergent HA mutations correlate with decreased immunity to influenza virus.
Keyphrases